The underlying physical properties of microfluidic tools have led to new biological insights
through the development of microsystems that can manipulate, mimic and measure biology …

Methods to detect immunolabeled molecules at increasingly higher resolutions, even when
present at low levels, are revolutionizing immunohistochemistry (IHC). These technologies …

With the introduction of recent high‐throughput technologies to various fields of science and
medicine, it is becoming clear that obtaining large amounts of data is no longer a problem in …

The remarkable success of targeted immunotherapies is revolutionizing cancer treatment.
However, tumor heterogeneity and low immunogenicity, in addition to several tumor …

Abstract Cytokeratin fragment antigen 21–1 (CYFRA 21–1) DNA is a crucial biomarker
closely associated with non-small cell lung cancer. Here, we fabricated a novel …

Lab-on-a-chip (LoC) systems allow the implementation of benchtop analytical
methods/protocols using low reagent volumes, short processing times, and this potentially at …

Abnormal uterine bleeding (AUB) is an extremely common problem and represents a clinical
area of unmet need. It has clinical implications and a high cost for the healthcare system …

Biomarker analysis is playing an essential role in cancer diagnosis, prognosis, and
prediction. Quantitative assessment of immunohistochemical biomarker expression on tumor …

Biochemical reaction rates in microfluidic systems are known to be limited by the diffusional
transport of reagents, leading often to lowered sensitivity and/or longer detection times in …

Advances in liquid chromatography tandem mass spectrometry (LC–MS/MS) have permitted
phosphoproteomic analysis on a grand scale, but ongoing challenges specifically …